{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T02:27:01Z","timestamp":1791685621600,"version":"4.3.4"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,6,15]]},"DOI":"10.7759\/cureus.40463","type":"journal-article","created":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T13:49:09Z","timestamp":1686836949000},"source":"Crossref","is-referenced-by-count":33,"title":["The Role of Sirtuin 1 (SIRT1) in Neurodegeneration"],"prefix":"10.7759","author":[{"given":"Daniel I","family":"Razick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muzammil","family":"Akhtar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimmy","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meraj","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabeal","family":"Dean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Karabala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ubaid","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaid","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan","family":"Tabaie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shakeel","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2174\/1389557516666160620095103","article-title":"Small molecules as SIRT modulators","volume":"18","author":"Bai X","year":"2018","unstructured":"Bai X, Yao L, Ma X, Xu X. Small molecules as SIRT modulators. Mini Rev Med Chem. 2018, 18:1151-7. 10.2174\/1389557516666160620095103","journal-title":"Mini Rev Med Chem"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/nrm3293","article-title":"Sirtuins as regulators of metabolism and healthspan","volume":"13","author":"Houtkooper RH","year":"2012","unstructured":"Houtkooper RH, Pirinen E, Auwerx J. Sirtuins as regulators of metabolism and healthspan. Nat Rev Mol Cell Biol. 2012, 13:225-38. 10.1038\/nrm3293","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbapap.2009.12.021","article-title":"Mitochondrial sirtuins","volume":"1804","author":"Huang JY","year":"2010","unstructured":"Huang JY, Hirschey MD, Shimazu T, Ho L, Verdin E. Mitochondrial sirtuins. Biochim Biophys Acta. 2010, 1804:1645-51. 10.1016\/j.bbapap.2009.12.021","journal-title":"Biochim Biophys Acta"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1101\/gad.1412706","article-title":"SirT2 is a histone deacetylase with preference for histone H4 Lys 16 during mitosis","volume":"20","author":"Vaquero A","year":"2006","unstructured":"Vaquero A, Scher MB, Lee DH, et al.. SirT2 is a histone deacetylase with preference for histone H4 Lys 16 during mitosis. Genes Dev. 2006, 20:1256-61. 10.1101\/gad.1412706","journal-title":"Genes Dev"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1021\/bi802093g","article-title":"Investigating the ADP-ribosyltransferase activity of sirtuins with NAD analogues and 32P-NAD","volume":"48","author":"Du J","year":"2009","unstructured":"Du J, Jiang H, Lin H. Investigating the ADP-ribosyltransferase activity of sirtuins with NAD analogues and 32P-NAD. Biochemistry. 2009, 48:2878-90. 10.1021\/bi802093g","journal-title":"Biochemistry"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.R112.378877","article-title":"Sirtuin catalysis and regulation","volume":"287","author":"Feldman JL","year":"2012","unstructured":"Feldman JL, Dittenhafer-Reed KE, Denu JM. Sirtuin catalysis and regulation. J Biol Chem. 2012, 287:42419-27. 10.1074\/jbc.R112.378877","journal-title":"J Biol Chem"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.11.046","article-title":"Sirtuin 4 is a lipoamidase regulating pyruvate dehydrogenase complex activity","volume":"159","author":"Mathias RA","year":"2014","unstructured":"Mathias RA, Greco TM, Oberstein A, et al.. Sirtuin 4 is a lipoamidase regulating pyruvate dehydrogenase complex activity. Cell. 2014, 159:1615-25. 10.1016\/j.cell.2014.11.046","journal-title":"Cell"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/anie.201402679","article-title":"Chemical probing of the human sirtuin 5 active site reveals its substrate acyl specificity and peptide-based inhibitors","volume":"53","author":"Roessler C","year":"2014","unstructured":"Roessler C, Nowak T, Pannek M, et al.. Chemical probing of the human sirtuin 5 active site reveals its substrate acyl specificity and peptide-based inhibitors. Angew Chem Int Ed Engl. 2014, 53:10728-32. 10.1002\/anie.201402679","journal-title":"Angew Chem Int Ed Engl"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1474-9726.2007.00335.x","article-title":"SIRT1 transgenic mice show phenotypes resembling calorie restriction","volume":"6","author":"Bordone L","year":"2007","unstructured":"Bordone L, Cohen D, Robinson A, et al.. SIRT1 transgenic mice show phenotypes resembling calorie restriction. Aging Cell. 2007, 6:759-67. 10.1111\/j.1474-9726.2007.00335.x","journal-title":"Aging Cell"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.mad.2005.03.013","article-title":"Calorie restriction and SIR2 genes--towards a mechanism","volume":"126","author":"Guarente L","year":"2005","unstructured":"Guarente L. Calorie restriction and SIR2 genes--towards a mechanism. Mech Ageing Dev. 2005, 126:923-8. 10.1016\/j.mad.2005.03.013","journal-title":"Mech Ageing Dev"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0404184101","article-title":"Sir2 mediates longevity in the fly through a pathway related to calorie restriction","volume":"101","author":"Rogina B","year":"2004","unstructured":"Rogina B, Helfand SL. Sir2 mediates longevity in the fly through a pathway related to calorie restriction. Proc Natl Acad Sci U S A. 2004, 101:15998-6003. 10.1073\/pnas.0404184101","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbapap.2010.05.002","article-title":"SIRT1 and p53, effect on cancer, senescence and beyond","volume":"1804","author":"Yi J","year":"2010","unstructured":"Yi J, Luo J. SIRT1 and p53, effect on cancer, senescence and beyond. Biochim Biophys Acta. 2010, 1804:1684-9. 10.1016\/j.bbapap.2010.05.002","journal-title":"Biochim Biophys Acta"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.5.147","article-title":"SIRT1, is it a tumor promoter or tumor suppressor?","volume":"5","author":"Deng CX","year":"2009","unstructured":"Deng CX. SIRT1, is it a tumor promoter or tumor suppressor?. Int J Biol Sci. 2009, 5:147-52. 10.7150\/ijbs.5.147","journal-title":"Int J Biol Sci"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/837042","article-title":"Properties of resveratrol: In vitro and in vivo studies about metabolism, bioavailability, and biological effects in animal models and humans","volume":"2015","author":"Gambini J","year":"2015","unstructured":"Gambini J, Ingl\u00e9s M, Olaso G, et al.. Properties of resveratrol: In vitro and in vivo studies about metabolism, bioavailability, and biological effects in animal models and humans. Oxid Med Cell Longev. 2015, 2015:837042. 10.1155\/2015\/837042","journal-title":"Oxid Med Cell Longev"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1515\/revneuro-2021-0118","article-title":"The protective effects of activating sirt1\/NF-\u03baB pathway for neurological disorders","volume":"33","author":"Song Y","year":"2022","unstructured":"Song Y, Wu Z, Zhao P. The protective effects of activating sirt1\/NF-\u03baB pathway for neurological disorders. Rev Neurosci. 2022, 33:427-38. 10.1515\/revneuro-2021-0118","journal-title":"Rev Neurosci"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1021\/acschemneuro.0c00775","article-title":"Olmesartan prevents oligomerized amyloid \u03b2 (A\u03b2)-induced cellular senescence in neuronal cells","volume":"12","author":"Wang J","year":"2021","unstructured":"Wang J, Zheng B, Yang S, Zhou D, Wang J. Olmesartan prevents oligomerized amyloid \u03b2 (A\u03b2)-induced cellular senescence in neuronal cells. ACS Chem Neurosci. 2021, 12:1162-9. 10.1021\/acschemneuro.0c00775","journal-title":"ACS Chem Neurosci"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-016-0224-3","article-title":"Sirtuin functions and modulation: from chemistry to the clinic","volume":"8","author":"Carafa V","year":"2016","unstructured":"Carafa V, Rotili D, Forgione M, et al.. Sirtuin functions and modulation: from chemistry to the clinic. Clin Epigenetics. 2016, 8:61. 10.1186\/s13148-016-0224-3","journal-title":"Clin Epigenetics"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20070140","article-title":"Sirtuins in mammals: insights into their biological function","volume":"404","author":"Michan S","year":"2007","unstructured":"Michan S, Sinclair D. Sirtuins in mammals: insights into their biological function. Biochem J. 2007, 404:1-13. 10.1042\/BJ20070140","journal-title":"Biochem J"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.285031","article-title":"SIRT1 contains N- and C-terminal regions that potentiate deacetylase activity","volume":"287","author":"Pan M","year":"2012","unstructured":"Pan M, Yuan H, Brent M, Ding EC, Marmorstein R. SIRT1 contains N- and C-terminal regions that potentiate deacetylase activity. J Biol Chem. 2012, 287:2468-76. 10.1074\/jbc.M111.285031","journal-title":"J Biol Chem"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20120121","article-title":"Molecular architecture of the human protein deacetylase sirt1 and its regulation by AROS and resveratrol","volume":"33","author":"Lakshminarasimhan M","year":"2013","unstructured":"Lakshminarasimhan M, Curth U, Moniot S, Mosalaganti S, Raunser S, Steegborn C. Molecular architecture of the human protein deacetylase sirt1 and its regulation by AROS and resveratrol. Biosci Rep. 2013, 33:e00037. 10.1042\/BSR20120121","journal-title":"Biosci Rep"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/6782872","article-title":"The beneficial roles of SIRT1 in neuroinflammation-related diseases","volume":"2020","author":"Jiao F","year":"2020","unstructured":"Jiao F, Gong Z. The beneficial roles of SIRT1 in neuroinflammation-related diseases. Oxid Med Cell Longev. 2020, 2020:6782872. 10.1155\/2020\/6782872","journal-title":"Oxid Med Cell Longev"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.250422697","article-title":"Silent information regulator 2 family of NAD- dependent histone\/protein deacetylases generates a unique product, 1-O-acetyl-ADP-ribose","volume":"97","author":"Tanner KG","year":"2000","unstructured":"Tanner KG, Landry J, Sternglanz R, Denu JM. Silent information regulator 2 family of NAD- dependent histone\/protein deacetylases generates a unique product, 1-O-acetyl-ADP-ribose. Proc Natl Acad Sci U S A. 2000, 97:14178-82. 10.1073\/pnas.250422697","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.831168","article-title":"Regulation of SIRT1 and its roles in inflammation","volume":"13","author":"Yang Y","year":"2022","unstructured":"Yang Y, Liu Y, Wang Y, et al.. Regulation of SIRT1 and its roles in inflammation. Front Immunol. 2022, 13:831168. 10.3389\/fimmu.2022.831168","journal-title":"Front Immunol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.14348\/molcells.2016.2318","article-title":"Sirt1 and the mitochondria","volume":"39","author":"Tang BL","year":"2016","unstructured":"Tang BL. Sirt1 and the mitochondria. Mol Cells. 2016, 39:87-95. 10.14348\/molcells.2016.2318","journal-title":"Mol Cells"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0604392103","article-title":"Sirtuins deacetylate and activate mammalian acetyl-CoA synthetases","volume":"103","author":"Hallows WC","year":"2006","unstructured":"Hallows WC, Lee S, Denu JM. Sirtuins deacetylate and activate mammalian acetyl-CoA synthetases. Proc Natl Acad Sci U S A. 2006, 103:10230-5. 10.1073\/pnas.0604392103","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2008.388","article-title":"Deacetylation of cortactin by SIRT1 promotes cell migration","volume":"28","author":"Zhang Y","year":"2009","unstructured":"Zhang Y, Zhang M, Dong H, et al.. Deacetylation of cortactin by SIRT1 promotes cell migration. Oncogene. 2009, 28:445-60. 10.1038\/onc.2008.388","journal-title":"Oncogene"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M501485200","article-title":"SIRT1 functionally interacts with the metabolic regulator and transcriptional coactivator PGC-1{alpha}","volume":"280","author":"Nemoto S","year":"2005","unstructured":"Nemoto S, Fergusson MM, Finkel T. SIRT1 functionally interacts with the metabolic regulator and transcriptional coactivator PGC-1{alpha}. J Biol Chem. 2005, 280:16456-60. 10.1074\/jbc.M501485200","journal-title":"J Biol Chem"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.15252\/embj.201695737","article-title":"SIRT1 regulates macrophage self-renewal","volume":"36","author":"Imperatore F","year":"2017","unstructured":"Imperatore F, Maurizio J, Vargas Aguilar S, et al.. SIRT1 regulates macrophage self-renewal. EMBO J. 2017, 36:2353-72. 10.15252\/embj.201695737","journal-title":"EMBO J"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.106014","article-title":"SIRT1-FOXOs activity regulates diabetic complications","volume":"175","author":"Jalgaonkar MP","year":"2022","unstructured":"Jalgaonkar MP, Parmar UM, Kulkarni YA, Oza MJ. SIRT1-FOXOs activity regulates diabetic complications. Pharmacol Res. 2022, 175:106014. 10.1016\/j.phrs.2021.106014","journal-title":"Pharmacol Res"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.dnarep.2009.12.020","article-title":"Role of SIRT1 in homologous recombination","volume":"9","author":"Uhl M","year":"2010","unstructured":"Uhl M, Csernok A, Aydin S, Kreienberg R, Wiesm\u00fcller L, Gatz SA. Role of SIRT1 in homologous recombination. DNA Repair (Amst). 2010, 9:383-93. 10.1016\/j.dnarep.2009.12.020","journal-title":"DNA Repair (Amst)"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/cdf660","article-title":"Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-kappaB","volume":"21","author":"Chen LF","year":"2002","unstructured":"Chen LF, Mu Y, Greene WC. Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-kappaB. EMBO J. 2002, 21:6539-48. 10.1093\/emboj\/cdf660","journal-title":"EMBO J"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagen.2021.129952","article-title":"Trending topics of SIRT1 in tumorigenicity","volume":"1865","author":"Garcia-Peterson LM","year":"2021","unstructured":"Garcia-Peterson LM, Li X. Trending topics of SIRT1 in tumorigenicity. Biochim Biophys Acta Gen Subj. 2021, 1865:129952. 10.1016\/j.bbagen.2021.129952","journal-title":"Biochim Biophys Acta Gen Subj"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.779177","article-title":"SIRT1: a potential therapeutic target in autoimmune diseases","volume":"12","author":"Shen P","year":"2021","unstructured":"Shen P, Deng X, Chen Z, et al.. SIRT1: a potential therapeutic target in autoimmune diseases. Front Immunol. 2021, 12:779177. 10.3389\/fimmu.2021.779177","journal-title":"Front Immunol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S140188","article-title":"Mechanisms of NF-\u03baB p65 and strategies for therapeutic manipulation","volume":"11","author":"Giridharan S","year":"2018","unstructured":"Giridharan S, Srinivasan M. Mechanisms of NF-\u03baB p65 and strategies for therapeutic manipulation. J Inflamm Res. 2018, 11:407-19. 10.2147\/JIR.S140188","journal-title":"J Inflamm Res"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M509329200","article-title":"SIRT1 protects against microglia-dependent amyloid-beta toxicity through inhibiting NF-kappaB signaling","volume":"280","author":"Chen J","year":"2005","unstructured":"Chen J, Zhou Y, Mueller-Steiner S, et al.. SIRT1 protects against microglia-dependent amyloid-beta toxicity through inhibiting NF-kappaB signaling. J Biol Chem. 2005, 280:40364-74. 10.1074\/jbc.M509329200","journal-title":"J Biol Chem"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2022.967813","article-title":"Neuroprotective and therapeutic effects of calcitriol in rotenone-induced Parkinson's disease rat model","volume":"16","author":"Magdy A","year":"2022","unstructured":"Magdy A, Farrag EA, Hamed SM, et al.. Neuroprotective and therapeutic effects of calcitriol in rotenone-induced Parkinson's disease rat model. Front Cell Neurosci. 2022, 16:967813. 10.3389\/fncel.2022.967813","journal-title":"Front Cell Neurosci"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.2005375","article-title":"Inflammatory stimuli induce inhibitory S-nitrosylation of the deacetylase SIRT1 to increase acetylation and activation of p53 and p65","volume":"7","author":"Shinozaki S","year":"2014","unstructured":"Shinozaki S, Chang K, Sakai M, et al.. Inflammatory stimuli induce inhibitory S-nitrosylation of the deacetylase SIRT1 to increase acetylation and activation of p53 and p65. Sci Signal. 2014, 7:ra106. 10.1126\/scisignal.2005375","journal-title":"Sci Signal"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2017.00170","article-title":"Autophagy and its impact on neurodegenerative diseases: new roles for TDP-43 and C9ORF72","volume":"10","author":"Budini M","year":"2017","unstructured":"Budini M, Buratti E, Morselli E, Criollo A. Autophagy and its impact on neurodegenerative diseases: new roles for TDP-43 and C9ORF72. Front Mol Neurosci. 2017, 10:170. 10.3389\/fnmol.2017.00170","journal-title":"Front Mol Neurosci"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.15002","article-title":"Autophagy in neurodegeneration: new insights underpinning therapy for neurological diseases","volume":"154","author":"Corti O","year":"2020","unstructured":"Corti O, Blomgren K, Poletti A, Beart PM. Autophagy in neurodegeneration: new insights underpinning therapy for neurological diseases. J Neurochem. 2020, 154:354-71. 10.1111\/jnc.15002","journal-title":"J Neurochem"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111480","article-title":"Oligodendroglial macroautophagy is essential for myelin sheath turnover to prevent neurodegeneration and death","volume":"41","author":"Aber ER","year":"2022","unstructured":"Aber ER, Griffey CJ, Davies T, et al.. Oligodendroglial macroautophagy is essential for myelin sheath turnover to prevent neurodegeneration and death. Cell Rep. 2022, 41:111480. 10.1016\/j.celrep.2022.111480","journal-title":"Cell Rep"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1038\/nature07813","article-title":"AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity","volume":"458","author":"Cant\u00f3 C","year":"2009","unstructured":"Cant\u00f3 C, Gerhart-Hines Z, Feige JN, et al.. AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature. 2009, 458:1056-60. 10.1038\/nature07813","journal-title":"Nature"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M805711200","article-title":"SIRT1 modulation of the acetylation status, cytosolic localization, and activity of LKB1. Possible role in AMP-activated protein kinase activation","volume":"283","author":"Lan F","year":"2008","unstructured":"Lan F, Cacicedo JM, Ruderman N, Ido Y. SIRT1 modulation of the acetylation status, cytosolic localization, and activity of LKB1. Possible role in AMP-activated protein kinase activation. J Biol Chem. 2008, 283:27628-35. 10.1074\/jbc.M805711200","journal-title":"J Biol Chem"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.646817","article-title":"Baicalein induces mitochondrial autophagy to prevent Parkinson\u2019s disease in rats via miR-30b and the SIRT1\/AMPK\/mTOR pathway","volume":"12","author":"Chen M","year":"2021","unstructured":"Chen M, Peng L, Gong P, Zheng X, Sun T, Zhang X, Huo J. Baicalein induces mitochondrial autophagy to prevent Parkinson\u2019s disease in rats via miR-30b and the SIRT1\/AMPK\/mTOR pathway. Front Neurol. 2021, 12:646817. 10.3389\/fneur.2021.646817","journal-title":"Front Neurol"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22168424","article-title":"miR-302 attenuates mutant huntingtin-induced cytotoxicity through restoration of autophagy and insulin sensitivity","volume":"22","author":"Chang CC","year":"2021","unstructured":"Chang CC, Tsou SH, Chen WJ, et al.. miR-302 attenuates mutant huntingtin-induced cytotoxicity through restoration of autophagy and insulin sensitivity. Int J Mol Sci. 2021, 22:8424. 10.3390\/ijms22168424","journal-title":"Int J Mol Sci"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1002\/prot.10173","article-title":"Identification of the N-terminal functional domains of Cdk5 by molecular truncation and computer modeling","volume":"48","author":"Zhang J","year":"2002","unstructured":"Zhang J, Luan CH, Chou KC, Johnson GV. Identification of the N-terminal functional domains of Cdk5 by molecular truncation and computer modeling. Proteins. 2002, 48:447-53. 10.1002\/prot.10173","journal-title":"Proteins"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.3133-06.2006","article-title":"p25\/cyclin-dependent kinase 5 induces production and intraneuronal accumulation of amyloid beta in vivo","volume":"26","author":"Cruz JC","year":"2006","unstructured":"Cruz JC, Kim D, Moy LY, Dobbin MM, Sun X, Bronson RT, Tsai LH. p25\/cyclin-dependent kinase 5 induces production and intraneuronal accumulation of amyloid beta in vivo. J Neurosci. 2006, 26:10536-41. 10.1523\/JNEUROSCI.3133-06.2006","journal-title":"J Neurosci"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2007.08.030","article-title":"Active regulator of SIRT1 cooperates with SIRT1 and facilitates suppression of p53 activity","volume":"28","author":"Kim EJ","year":"2007","unstructured":"Kim EJ, Kho JH, Kang MR, Um SJ. Active regulator of SIRT1 cooperates with SIRT1 and facilitates suppression of p53 activity. Mol Cell. 2007, 28:277-90. 10.1016\/j.molcel.2007.08.030","journal-title":"Mol Cell"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2020.135465","article-title":"Upregulation of mir-132 induces dopaminergic neuronal death via activating SIRT1\/P53 pathway","volume":"740","author":"Qazi TJ","year":"2021","unstructured":"Qazi TJ, Lu J, Duru L, Zhao J, Qing H. Upregulation of mir-132 induces dopaminergic neuronal death via activating SIRT1\/P53 pathway. Neurosci Lett. 2021, 740:135465. 10.1016\/j.neulet.2020.135465","journal-title":"Neurosci Lett"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1007\/s11882-013-0417-1","article-title":"Etiology and pathogenesis of late-onset Alzheimer's disease","volume":"14","author":"Balin BJ","year":"2014","unstructured":"Balin BJ, Hudson AP. Etiology and pathogenesis of late-onset Alzheimer's disease. Curr Allergy Asthma Rep. 2014, 14:417. 10.1007\/s11882-013-0417-1","journal-title":"Curr Allergy Asthma Rep"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00702","article-title":"Brain SIRT1 mediates metabolic homeostasis and neuroprotection","volume":"9","author":"Xu J","year":"2018","unstructured":"Xu J, Jackson CW, Khoury N, Escobar I, Perez-Pinzon MA. Brain SIRT1 mediates metabolic homeostasis and neuroprotection. Front Endocrinol (Lausanne). 2018, 9:702. 10.3389\/fendo.2018.00702","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1038\/nrm1616","article-title":"Calorie restriction, SIRT1 and metabolism: understanding longevity","volume":"6","author":"Bordone L","year":"2005","unstructured":"Bordone L, Guarente L. Calorie restriction, SIRT1 and metabolism: understanding longevity. Nat Rev Mol Cell Biol. 2005, 6:298-305. 10.1038\/nrm1616","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1111\/ene.13413","article-title":"Huntington's disease: a clinical review","volume":"25","author":"McColgan P","year":"2018","unstructured":"McColgan P, Tabrizi SJ. Huntington's disease: a clinical review. Eur J Neurol. 2018, 25:24-34. 10.1111\/ene.13413","journal-title":"Eur J Neurol"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-444-63425-2.00010-6","article-title":"The role of dopamine in Huntington's disease","volume":"211","author":"Cepeda C","year":"2014","unstructured":"Cepeda C, Murphy KP, Parent M, Levine MS. The role of dopamine in Huntington's disease. Prog Brain Res. 2014, 211:235-54. 10.1016\/B978-0-444-63425-2.00010-6","journal-title":"Prog Brain Res"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-013-0055-0","article-title":"Targeting sirtuin-1 in Huntington's disease: rationale and current status","volume":"27","author":"Duan W","year":"2013","unstructured":"Duan W. Targeting sirtuin-1 in Huntington's disease: rationale and current status. CNS Drugs. 2013, 27:345-52. 10.1007\/s40263-013-0055-0","journal-title":"CNS Drugs"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.5114\/aoms.2015.56342","article-title":"Brain-derived neurotrophic factor and its clinical implications","volume":"11","author":"Bathina S","year":"2015","unstructured":"Bathina S, Das UN. Brain-derived neurotrophic factor and its clinical implications. Arch Med Sci. 2015, 11:1164-78. 10.5114\/aoms.2015.56342","journal-title":"Arch Med Sci"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2005.01.001","article-title":"Progressive loss of BDNF in a mouse model of Huntington's disease and rescue by BDNF delivery","volume":"52","author":"Zuccato C","year":"2005","unstructured":"Zuccato C, Liber D, Ramos C, et al.. Progressive loss of BDNF in a mouse model of Huntington's disease and rescue by BDNF delivery. Pharmacol Res. 2005, 52:133-9. 10.1016\/j.phrs.2005.01.001","journal-title":"Pharmacol Res"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2559","article-title":"Sirt1 mediates neuroprotection from mutant huntingtin by activation of the TORC1 and CREB transcriptional pathway","volume":"18","author":"Jeong H","year":"2011","unstructured":"Jeong H, Cohen DE, Cui L, et al.. Sirt1 mediates neuroprotection from mutant huntingtin by activation of the TORC1 and CREB transcriptional pathway. Nat Med. 2011, 18:159-65. 10.1038\/nm.2559","journal-title":"Nat Med"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/8152373","article-title":"Neuroprotective mechanisms of resveratrol in Alzheimer\u2019s disease: role of SIRT1","volume":"2018","author":"Gomes BA","year":"2018","unstructured":"Gomes BA, Silva JP, Romeiro CF, et al.. Neuroprotective mechanisms of resveratrol in Alzheimer\u2019s disease: role of SIRT1. Oxid Med Cell Longev. 2018, 2018:8152373. 10.1155\/2018\/8152373","journal-title":"Oxid Med Cell Longev"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/9148650","article-title":"Effect of resveratrol combined with donepezil hydrochloride on inflammatory factor level and cognitive function level of patients with Alzheimer\u2019s disease","volume":"2022","author":"Fang X","year":"2022","unstructured":"Fang X, Zhang J, Zhao J, Wang L. Effect of resveratrol combined with donepezil hydrochloride on inflammatory factor level and cognitive function level of patients with Alzheimer\u2019s disease. J Healthc Eng. 2022, 2022:9148650. 10.1155\/2022\/9148650","journal-title":"J Healthc Eng"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-016-0779-0","article-title":"Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer's disease","volume":"14","author":"Moussa C","year":"2017","unstructured":"Moussa C, Hebron M, Huang X, Ahn J, Rissman RA, Aisen PS, Turner RS. Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer's disease. J Neuroinflammation. 2017, 14:1. 10.1186\/s12974-016-0779-0","journal-title":"J Neuroinflammation"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-013-8401-2","article-title":"Neuroprotective effects of resveratrol against A\u03b2 administration in rats are improved by lipid-core nanocapsules","volume":"47","author":"Frozza RL","year":"2013","unstructured":"Frozza RL, Bernardi A, Hoppe JB, et al.. Neuroprotective effects of resveratrol against A\u03b2 administration in rats are improved by lipid-core nanocapsules. Mol Neurobiol. 2013, 47:1066-80. 10.1007\/s12035-013-8401-2","journal-title":"Mol Neurobiol"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1111\/j.1527-3458.2008.00042.x","article-title":"Protective effects of cilostazol against transient focal cerebral ischemia and chronic cerebral hypoperfusion injury","volume":"14","author":"Lee JH","year":"2008","unstructured":"Lee JH, Park SY, Shin HK, Kim CD, Lee WS, Hong KW. Protective effects of cilostazol against transient focal cerebral ischemia and chronic cerebral hypoperfusion injury. CNS Neurosci Ther. 2008, 14:143-52. 10.1111\/j.1527-3458.2008.00042.x","journal-title":"CNS Neurosci Ther"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-018-00708-x","article-title":"Efficacy of cilostazol administration in Alzheimer\u2019s disease patients with white matter lesions: a positron-emission tomography study","volume":"16","author":"Lee JY","year":"2019","unstructured":"Lee JY, Lee H, Yoo HB, et al.. Efficacy of cilostazol administration in Alzheimer\u2019s disease patients with white matter lesions: a positron-emission tomography study. Neurotherapeutics. 2019, 16:394-403. 10.1007\/s13311-018-00708-x","journal-title":"Neurotherapeutics"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0134486","article-title":"Cilostazol upregulates autophagy via SIRT1 activation: reducing amyloid-\u03b2 peptide and app-ctf\u03b2 levels in neuronal cells","volume":"10","author":"Lee HR","year":"2015","unstructured":"Lee HR, Shin HK, Park SY, et al.. Cilostazol upregulates autophagy via SIRT1 activation: reducing amyloid-\u03b2 peptide and app-ctf\u03b2 levels in neuronal cells. PLoS One. 2015, 10:e0134486. 10.1371\/journal.pone.0134486","journal-title":"PLoS One"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/159084-the-role-of-sirtuin-1-sirt1-in-neurodegeneration","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:59:27Z","timestamp":1707508767000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/159084-the-role-of-sirtuin-1-sirt1-in-neurodegeneration"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,15]]},"references-count":64,"URL":"https:\/\/doi.org\/10.7759\/cureus.40463","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6,15]]}}}